The Patent Finder

Antibody Neutralizing Human Respiratory Syncytial Virus

Merck Sharp and Dohme LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 8 of these applications claim priority to application 62/367,359, filed Jul 27, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,963,500Antibody Neutralizing Human Respiratory Syncytial Virus
In force
 · High confidence
Merck Sharp & Dohme LLCIn force
High confidence
US 10,072,072Antibody Neutralizing Human Respiratory Syncytial Virus
In force
 · High confidence
Merck Sharp & Dohme LLCIn force
High confidence
US 10,323,079Antibody Neutralizing Human Respiratory Syncytial Virus
In force
 · Medium confidence
Merck Sharp & Dohme LLCIn force
Medium confidence
US 10,358,480Antibody Neutralizing Human Respiratory Syncytial Virus
In force
 · High confidence
Merck Sharp & Dohme LLCIn force
High confidence
US 11,008,380Antibody Neutralizing Human Respiratory Syncytial Virus
In force
 · High confidence
Merck Sharp & Dohme LLCIn force
High confidence
US 11,981,726Antibody Neutralizing Human Respiratory Syncytial Virus
In force
 · High confidence
Merck Sharp & Dohme LLCIn force
High confidence
US 12,371,478Antibody Neutralizing Human Respiratory Syncytial Virus
In force
 · High confidence
Merck Sharp & Dohme LLCIn force
High confidence
US 11,566,065Antibody Neutralizing Human Respiratory Syncytial Virus
In force
 · High confidence
Merck Sharp & Dohme LLCIn force
High confidence
Application 19/250,874Antibody Neutralizing Human Respiratory Syncytial Virus
Pending
Not granted
Merck Sharp & Dohme LLCPendingNot granted
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
8 of these are in force and held by Merck Sharp and Dohme LLC.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited